Entamoeba histolytica adheres to human colonic mucus, colonic epithelial cells, and other target cells via a galactose (Gal) or N-acetyl-D-galactosamine (GalNAc) inhibitable surface lectin. Blockade of this adherence lectin with Gal or GalNAc in vitro prevents amebic killing of target cells. We have identified and purified the adherence lectin by two methods: affinity columns derivatized with galactose monomers or galactose terminal glycoproteins, and affinity columns and immunoblots prepared with monoclonal antibodies that inhibit amebic adherence. By both methods the adherence lectin was identified as a 170-kD secreted and membrane-bound amebic protein. The surface location of the lectin was confirmed by indirect immunofluorescence. Purified lectin competitively inhibited amebic adherence to target cells by binding to receptors on the target Chinese hamster ovary cells in a Galinhibitable manner.
Introduction
The protozoan parasite Entamoeba histolytica is estimated to infect 10% of the world's population (1) . Invasive amebiasis manifests as amebic colitis, which can be complicated by intestinal perforation and peritonitis or hepatic abscess, and results in at least 60,000 deaths worldwide each year (1) (2) (3) . There is evidence that natural immunity against recurrent invasive amebiasis exists (3, 4) but currently no vaccine is available to prevent amebic disease in the developing world. A major thrust of our research is to identify amebic proteins that play a critical role in pathogenesis and to which a host immune response should be directed.
Adherence of E. histolytica trophozoites to intestinal mucus, epithelium, and host inflammatory cells occurs before invasion in animal and in vitro models of amebiasis (5) (6) (7) (8) . A galactose (Gal)' and N-acetyl-D-glactosamine (GalNAc) inhibitable surface lectin mediates the adherence of E. histolytica trophozoites to Chinese hamster ovary (CHO) cells, certain bacteria, human erythrocytes, and fixed rat and human coThis paper was presented in part at the National Meeting ofthe American Federation of Clinical Research, Washington, DC, 1986 and has appeared in abstract form (1986. Clin. Res. 34:529A).
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lonic mucosa (6) (7) (8) (9) . Inhibition of the lectin with GalNAc blocks the establishment of in vitro adherence and prevents amebae from lysing CHO cells and human neutrophils (8) . Soluble protein preparations from disrupted E. histolytica trophozoites contain a galactose-and GalNAc-inhibitable lectin that agglutinates CHO cells and erythrocytes and is mitogenic for human lymphocytes (8, 9) . This lectin activity was found to be greater in virulent than avirulent strains of E. histolytica in axenic culture (8) . We report here the purification of this lectin, its localization to the amebic surface and extracellular medium, and its competitive inhibition of amebic adherence.
Methods
Cultivation and harvesting ofE. histolytica and CHO cells. Axenic E. histolytica, strain HM1-IMSS, were grown in medium TYI-S-33 (trypticase yeast extract, iron, and serum) with 100 U/ml of penicillin and 100 ,ug/ml of streptomycin sulfate (Pfizer, Inc., New York, NY) (10) [35] methionine (New England Nuclear, Boston, MA) for 2 h at 37°C. CHO cells were grown in F12 medium (Gibco, Grand Island, NY) with 10% fetal bovine serum and 100 U/ml of penicillin and 100 ,ug/ml streptomycin sulfate and harvested by trypsinization as described (6) .
Adherence of E. histolytica trophozoites to CHO cells. The measurement of E. histolytica trophozoite adherence to CHO cells was performed as previously described (6) . Briefly, amebic trophozoites (1 X 104) and CHO cells (2 X 105) in the presence or absence of carbohydrate were suspended together at 4°C in M 199 media (Gibco) containing 25 mM Hepes, pH 6.8 (Sigma Chemical Co.), 5.7 mM cysteine, 0.5% boVine serum albumin, and 10% heat-inactivated adult bovine serum (M 199s 
Results
Adherence of E. histolytica trophozoites to CHO cells. The adherence ofE. histolytica trophozoites to CHO cells, which is mediated by the parasite's galactose-and GalNAc-inhibitable surface lectin (6, 8, 16) , was inhibited by galactose terminal asialoglycoproteins at concentrations as low as 0.1 sg/ml (P < 0.01; Fig. 1 ). The low molecular weight (< 3 kD) asialofetuin glycopeptide (GP) prepared by the method of Baenziger and Fiete contains three terminal galactose residues (12) and was a 10-fold more potent inhibitor of amebic adherence than galactose monomers. Intact asialofetuin (ASF) with nine terminal galactose residues (12) , and ASOR (prepared by neuraminidase treatment of orosomucoid) with 11-16 terminal galactose residues ( 17), were 1,000-fold more potent than galactose in inhibiting E. histolytica adherence. Fetuin and orosomucoid, in which the galactose residues are concealed by terminal sialic acid residues (12, 17), had no effect on amebic adherence when studied at concentrations (0.01 mg/ml) in which ASF and ASOR were maximally inhibitory (Fig. 1) .
ASOR affinity chromatography purifcation of the amebic adherence lectin. ASOR, the most potent inhibitor of amebic adherence studied, was coupled to a l-ml column of Affigel 10 for affinity purification of the amebic lectin. Amebic proteins were metabolically labeled with [35S]methionine with an incorporation of 1-3 dpm/ng protein; conditioned culture medium and octylglucoside-solubilized amebae were separately applied to the ASOR-Affigel 10 affinity column. After extensive washing of the column with application buffer the column was eluted with 0.5 M galactose (Fig. 2 ) and the peak of [35S]-methionine radioactivity analyzed by SDS-PAGE.
The autoradiograph shown in Fig. 3 demonstrates that a 1 70-kD metabolically labeled E. histolytica protein was eluted by galactose from the ASOR affinity column to which either conditioned medium (lane A) or octylglucoside-solubilized amebae (lane C) had been applied. Two minor bands of -26 and 30 kD mol wt were also detectable. Galactose elution ofan orosomucoid-Affigel 10 column to which conditioned me- (Fig. 3, insert D) . The binding of the amebic adherence lectin to the ASOR column was blocked by 0.5 M galactose (Fig. 4, lane C) but not by 0.5 M glucose (lane B). Galactose oxidase treatment of the terminal galactose residues of ASOR also prevented the amebic lectin from binding to the ASOR affinity column, giving further evidence that the amebic adherence lectin was binding to the terminal galactose residues of ASOR (Fig. 5, lanes  H-K) . The lectin did not bind to a control Affigel 10 column (data not shown). Galactose affinity chromatography purification ofthe amebic adherence lectin. The adherence lectin was also successfully purified from conditioned culture medium with an affinity column composed ofp-aminophenyl-thio-(3-D-galactopyranoside linked to silica beads (Fig. 5, lanes A-D) .
Monoclonal antibody H8-5 affinity chromatography purification of the amebic adherence lectin. The H8-5 antiamebic monoclonal antibody has previously been shown to inhibit amebic adherence (16) specific elution ofa 1 70-kD protein which comigrated with the adherence lectin purified on the ASOR and galactose affinity columns (Fig. 5 , lanes E-G).
Immunoblots with the F14 adherence-inhibitory monoclonal antibody. Of the several monoclonal antibodies which we have reported that inhibit the adherence of E. histolytica trophozoites to CHO cells, only one (F14) recognizes SDS and fl-mercaptoethanol denatured amebic proteins on immunoblots (16) . To test whether F14 monoclonal antibody was binding to the same 170-kD amebic protein isolated by the ASOR affinity column, immunoblots (Western blots) were performed. The galactose eluate from the ASOR-Affigel 10 column was subjected to SDS-PAGE and then electrophoretically transferred to nitrocellulose (15) . Excess protein binding capacity of the nitrocellulose was blocked with 5% nonfat dry milk and the nitrocellulose probed with the inhibitory monoclonal antibody. The nitrocellulose was extensively washed before visualizing the bound monoclonal antibodies with an anti-mouse horseradish peroxidase-antibody conjugate.
The immunoblot in Fig. 6 demonstrates that the F14 monoclonal antibody, which inhibited amebic adherence by 86% (16) , recognized the identical 170-kD protein isolated from conditioned culture medium (A) and detergent-solubilized amebae (B) by ASOR affinity chromatography. The minor protein bands at 26 and 30 kD eluted from the ASOR column were not recognized by the F14 monoclonal antibody. As shown in Fig. 7 , the F14 monoclonal antibody recognized only the 170-kD protein when whole amebae were immunoblotted as well. A total of three monoclonal antibodies that inhibited amebic adherence recognized the native lectin which was eluted from the H8-5 column and dotted on nitrocellulose (Fig. 8) . Three anti-amebic monoclonal antibodies tested which did not inhibit adherence did not bind to the nondenatured lectin. The three adherence-inhibitory monoclonal antibodies bound in a uniform manner to the surface of viable trophozoites at 4°C as determined by indirect immunofluorescence and demonstrated capping upon warming to 20°C (Fig.  9) . No immunofluorescence was observed in the absence of primary antibody or when the D10 monoclonal antibody which does not inhibit amebic adherence was used (data not shown).
Competitive inhibition of amebic adherence to CHO cells by the purified lectin. To further substantiate that the 170-kD Gal/GalNAc lectin isolated mediates amebic adherence, we determined the ability of lectin purified by H8-5 immunoaf- finity chromatography to occupy receptor sites on target cells. CHO cells were pre-exposed to the purified amebic adherence lectin (0.4-1.6 ,ug/104 CHO cells) for 60 min on ice and then washed twice before adding amebae and measuring adherence. The adherence lectin significantly inhibited amebic adherence to the pre-exposed CHO cells in a dose-dependent fashion (Fig.  10 ). This lectin-mediated inhibition of amebic adherence was blocked by the presence of0.25 M Gal or GalNAc but not 0.25 M dextrose in the preincubation mixture (Table I) .
Discussion
The Gal/GalNAc adherence lectin of E. histolytica has been identified as a 1 70-kD protein independently by adherence-inhibitory monoclonal antibodies and by affinity chromatography with ASOR and galactose, potent inhibitors of amebic adherence. The purified Gal/GalNAc adherence lectin retains its biologic activity, competitively inhibiting amebic adherence to CHO cells in a Gal-or GalNAc-specific fashion. The importance of the indentification of this protein rests in its probable central role in the pathogenesis of amebiasis. The sequence of events in the pathogenesis of invasive amebiasis include intestinal colonization by the parasite, adherence to colonic mucus and host cells, depletion and lysis of the mucus blanket, and disruption of the colonic epithelium accompanied by amebic contact-dependent lysis of host epithelial and inflammatory cells (5, 18) . Inhibition of the lectin with GalNAc blocks not only amebic adherence to host cells and colonic mucus (7-9; see following companion paper) but also contact-dependent killing of target cells (6) (7) (8) (9) . GalNAc-mediated inhibition of amebic adherence and cytolytic activity also provides the opportunity for human neutrophils in vitro to kill the trophozoites and limit tissue damage (9, 19) . We determined the effect of galactose-terminal asialoglycoproteins on amebic adherence to CHO cells to identify a high-affinity ligand for subsequent use in purification. Ravdin and Guerrant (6) tose and GalNAc at concentrations of 10 mg/ml would completely inhibit amebic adherence to CHO cells, whereas other sugars such as mannose, neuraminic acid, and N-acetyl glucosamine had no effect. Asialoglycoproteins with multiple terminal galactose residues proved to be much more potent inhibitors of amebic adherence than galactose or GalNAc monomers, with inhibition of adherence seen at concentrations of ASOR as low as 0.1 ,g/ml. The intact fetuin and orosomucoid molecules, with the galactose residues masked by terminal sialic acid residues, had no effect on amebic adherence and served as important negative controls in these experiments. The greater affinity of the 1 70-kD Gal/GalNAc amebic lectin for galactose terminal glycoproteins is similar to the binding affinities described for the asialoglycoprotein receptor of rabbit liver where, up to a threshold, increasing numbers of terminal galactose residues placed on a neoglycoprotein increased binding avidity (20) .
An earlier report from this laboratory (8) utilized Sephacryl S-300 gel filtration chromatography of amebic proteins to partially purify the lectin. The size of the lectin was erroneously estimated to be 43-67 kD in this report because SDS-PAGE of One physiologic receptor for the E. histolytica adherence lectin is colonic mucus, where amebic trophozoites are found attached before the production of invasive intestinal lesions in humans and animal models (5) (6) (7) (8) . Human colonic mucus is rich in galactose-terminal glycoproteins (21). Chadee et al. have now demonstrated that purified rat colonic mucin binds specifically to the amebic Gal/GalNAc lectin and that this binding can be inhibited by galactose (see companion paper). Adherence of amebae to colonic mucus may be a prerequisite for successful parasite colonization; a host mucosal antibody response to the Gal/GalNAc lectin has the potential to inhibit intestinal colonization by E. histolytica. The association ofthe Gal/GalNAc lectin with amebic virulence (8) may be analogous to the galactose binding lectins found in Escherichia coli (22) strains that more commonly colonize the urinary tract and cause pyelonephritis (23) .
The E. histolytica adherence lectin resembles other soluble lectins isolated from vertebrates and cellular slime molds in its specificity for f,-galactosides (24) . The existence of membrane and soluble forms of surface antigens has also been seen for the variant surface glycoproteins of trypanosomes where the membrane-bound form has an anchoring phospatidylinositol group (25) , and the cellular slime mold-soluble lectin that binds to a galactose-containing receptor on the slime mold surface (26) . The biochemical differences and the biologic significance of the membrane-bound and soluble forms of the amebic lectin are under investigation. Whereas the monoclonal antibody and carbohydrate inhibition data presented here demonstrate that the Gal/GalNAc lectin is almost completely responsible for amebic adherence to CHO cells in our system, other amebic proteins could be involved in amebic adherence to other cells. Recently antibody to a 12-kD protein has been shown to partially inhibit amebic adherence to red blood cells (27) .
A lectin is defined as "a sugar-binding protein or glycoprotein of nonimmune origin which agglutinates cells and/or precipitates glycoconjugates" (28) . We believe that we are justified in calling the 170-kD adherence protein a lectin by its galactose and GalNac-inhibitable binding to ASOR (Fig. 4) and its mitogenic properties for normal human lymphocytes (29). But it should be noted that we have not rigorously demonstrated its bivalency or polyvalency by cell agglutination or glycoconjugate precipitation assays.
Currently, there is no vaccine available for prevention of invasive amebiasis, the third leading parasitic cause of death worldwide and a source of substantial morbidity in the developing world (1) . Patients who have recovered from amebic liver abscess rarely have recurrent invasive amebiasis (4) . It thus may be of significance that the 1 70-kD amebic adherence lectin is recognized on immunoblots by the convalescent sera from patients with amebic liver abscess (30) . In animal models, cure of invasive infection or immunization with amebic proteins results in the development ofprotective immunity (31) (32) (33) . Present evidence in both humans and animal models indicates that acquired resistance to invasive amebiasis is associated with development of an effective cell-mediated response (33) (34) (35) . During acute disease in humans there is depression of cell-meditated immunity (36) antibody; has been shown to occur by means of a "capping" phenomenon (39, 40) that may be protective for the parasite. However, the role of serum or mucosal antibody in host resistance to intestinal colonization by the parasite has not been evaluated. The use of the major amebic adherence protein identified in this report to produce protective immunity in animal models of invasive amebiasis will be the focus of future studies.
